Hospital
Albany Medical Center Hospital
Albany Medical Center Hospital was paid $79.78M by Medicaid between Jan 2018 and Dec 2024, across 500 billing codes. Its largest line is 99284, emergency room visit (serious) — 8.9% of everything it billed.
33Billing provider infoALBANY MEDICAL CENTER HOSPITAL
ALBANY, NY 12208
ALBANY, NY 12208
33aNPI1376577247assigned 07/10/2006
33bProvider typeGeneral Acute Care Hospital
28Total paid$79.78M
24GClaims1,299,838
24DCodes billed500
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other General Acute Care Hospital providers in New York
Rank by total paid#19 of 231
Median peer was paid$561K
This provider vs. median142×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 13,971 | $669K | |
| 2019 | 86,448 | $4.71M | |
| 2020 | 219,754 | $14.76M | |
| 2021 | 246,291 | $15.15M | |
| 2022 | 249,802 | $15.05M | |
| 2023 | 265,983 | $16.84M | |
| 2024incomplete | 217,589 | $12.59M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 8.9% | 41,128 | 38,741 | $7.14M |
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 8.4% | 38,016 | 35,044 | $6.71M |
| J1745 | Injection, infliximab, excludes biosimilar, 10 mg | 5.3% | 1,344 | 1,296 | $4.21M |
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 4.8% | 23,684 | 22,101 | $3.86M |
| 43239 | Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple | 3.4% | 3,702 | 3,670 | $2.73M |
| 70450 | Computed tomography, head or brain; without contrast material | 3.3% | 7,868 | 7,596 | $2.63M |
| 90834 | Psychotherapy session, about 45 minutesPsychotherapy, 45 minutes with patient | 3.1% | 19,210 | 8,440 | $2.45M |
| 96415 | 2.9% | 3,177 | 2,933 | $2.33M | |
| 76700 | Ultrasound, abdominal, real time with image documentation; complete | 2.8% | 4,002 | 3,983 | $2.21M |
| 76856 | Ultrasound, pelvic (nonobstetric), real time with image documentation; complete | 2.6% | 3,864 | 3,788 | $2.10M |
| G0378 | Hospital observation service, per hour | 2.4% | 6,672 | 6,511 | $1.95M |
| J3490 | Unclassified drugs | 2.4% | 4,351 | 3,851 | $1.92M |
488 more codes
| U0004 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r | 2.3% | 16,739 | $1.87M |
| 80053 | Comprehensive metabolic panel | 2.1% | 59,230 | $1.71M |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 2.0% | 8,916 | $1.57M |
| 45380 | Colonoscopy, flexible; with biopsy, single or multiple | 1.9% | 1,744 | $1.48M |
| C1713 | Anchor/screw for opposing bone-to-bone or soft tissue-to-bone (implantable) | 1.8% | 1,342 | $1.45M |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | 1.7% | 4,865 | $1.33M |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | 1.5% | 7,753 | $1.18M |
| 99213 | Doctor's office visit, returning patient (routine) | 1.5% | 9,781 | $1.16M |
| 70553 | Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences | 1.4% | 2,157 | $1.09M |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | 1.1% | 10,964 | $847K |
| 96366 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour | <1% | 3,306 | $781K |
| 59025 | Fetal non-stress test | <1% | 3,026 | $746K |
| 76770 | <1% | 1,993 | $711K | |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | <1% | 2,180 | $674K |
| 36430 | <1% | 1,872 | $674K | |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | <1% | 9,659 | $640K |
| 87633 | Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets | <1% | 6,812 | $604K |
| 71275 | Computed tomographic angiography, chest, with contrast material | <1% | 1,614 | $581K |
| 70496 | <1% | 1,708 | $554K | |
| 99214 | Doctor's office visit, returning patient (more involved) | <1% | 4,292 | $550K |
| 70551 | Magnetic resonance imaging, brain; without contrast material | <1% | 1,136 | $518K |
| 86900 | <1% | 12,455 | $515K | |
| 12011 | <1% | 991 | $496K | |
| P9016 | Red blood cells, leukocytes reduced, each unit | <1% | 877 | $490K |
| 93308 | <1% | 1,605 | $459K | |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | <1% | 8,063 | $411K |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | <1% | 14,147 | $397K |
| 93975 | <1% | 649 | $395K | |
| 87536 | <1% | 2,613 | $389K | |
| 12001 | <1% | 732 | $377K | |
| 86901 | <1% | 12,735 | $374K | |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 8,511 | $367K |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 8,493 | $340K |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | <1% | 1,941 | $339K |
| 97140 | Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) | <1% | 5,946 | $338K |
| 97112 | Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination | <1% | 6,219 | $333K |
| 45378 | Colonoscopy, flexible; diagnostic, including collection of specimen(s) | <1% | 338 | $326K |
| 86850 | <1% | 12,300 | $321K | |
| 96361 | Intravenous infusion, hydration; each additional hour | <1% | 996 | $320K |
| 87798 | Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism | <1% | 8,224 | $313K |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 5,592 | $311K |
| 90836 | <1% | 5,460 | $305K | |
| 96413 | Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance | <1% | 4,348 | $296K |
| 90832 | Psychotherapy session, about 30 minutes | <1% | 2,107 | $283K |
| 87486 | <1% | 6,847 | $280K | |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | <1% | 866 | $274K |
| 45385 | Colonoscopy, flexible; with removal of tumor(s), polyp(s), or other lesion(s) | <1% | 300 | $259K |
| 43235 | <1% | 287 | $251K | |
| 76705 | Ultrasound, abdominal, real time with image documentation; limited | <1% | 4,619 | $243K |
| 86360 | <1% | 2,539 | $211K | |
| 87581 | <1% | 6,880 | $204K | |
| 88342 | <1% | 2,898 | $204K | |
| 92526 | <1% | 1,415 | $199K | |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 7,838 | $191K |
| 97161 | <1% | 1,216 | $156K | |
| 12002 | <1% | 290 | $156K | |
| 93970 | <1% | 223 | $156K | |
| 87661 | Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe | <1% | 4,271 | $154K |
| 70498 | <1% | 1,494 | $153K | |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 13,121 | $152K |
| 71260 | Computed tomography, thorax, diagnostic; with contrast material | <1% | 1,726 | $147K |
| 88185 | <1% | 548 | $145K | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 6,655 | $141K |
| 36415 | Collection of venous blood by venipuncture | <1% | 38,355 | $138K |
| J1561 | Injection, immune globulin, (gamunex-c/gammaked), non-lyophilized (e.g., liquid), 500 mg | <1% | 46 | $127K |
| 83880 | <1% | 3,019 | $126K | |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 64,752 | $119K |
| 87624 | Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types | <1% | 2,369 | $117K |
| 90792 | Psychiatric diagnostic evaluation with medical services | <1% | 512 | $107K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 3,990 | $107K |
| 84439 | <1% | 9,296 | $106K | |
| P9040 | Red blood cells, leukocytes reduced, irradiated, each unit | <1% | 174 | $106K |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | <1% | 5,925 | $104K |
| 97162 | <1% | 694 | $103K | |
| 86359 | <1% | 2,537 | $103K | |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | <1% | 575 | $102K |
| 36592 | <1% | 2,999 | $100K | |
| 70486 | <1% | 1,012 | $98K | |
| 87631 | <1% | 875 | $97K | |
| 90715 | <1% | 1,980 | $96K | |
| 76815 | Ultrasound, pregnant uterus, real time with image documentation, limited | <1% | 644 | $94K |
| 86480 | <1% | 1,027 | $94K | |
| 90833 | Psychotherapy, 30 minutes with patient when performed with an E&M service (add-on) | <1% | 2,763 | $92K |
| 95816 | <1% | 1,652 | $89K | |
| 88307 | <1% | 863 | $89K | |
| J2270 | Injection, morphine sulfate, up to 10 mg | <1% | 4,415 | $88K |
| 93976 | <1% | 492 | $86K | |
| 80061 | Lipid panel | <1% | 7,070 | $79K |
| 82728 | <1% | 4,159 | $78K | |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 6,003 | $78K |
| Q5104 | Injection, infliximab-abda, biosimilar, (renflexis), 10 mg | <1% | 124 | $77K |
| 88304 | <1% | 1,957 | $76K | |
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | <1% | 5,052 | $75K |
| 99215 | Doctor's office visit, returning patient (complex) | <1% | 584 | $73K |
| 83970 | <1% | 986 | $71K | |
| 51701 | <1% | 166 | $69K | |
| 88175 | Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer | <1% | 1,389 | $68K |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 11,232 | $68K |
| 87077 | <1% | 5,948 | $66K | |
| 88142 | <1% | 1,870 | $66K | |
| J3380 | Injection, vedolizumab, intravenous, 1 mg | <1% | 14 | $63K |
| 74230 | <1% | 358 | $63K | |
| 88341 | <1% | 930 | $62K | |
| 82784 | <1% | 2,854 | $59K | |
| 76830 | Ultrasound, transvaginal | <1% | 1,989 | $59K |
| 84403 | <1% | 1,236 | $58K | |
| 93971 | <1% | 627 | $55K | |
| 72125 | Computed tomography, cervical spine; without contrast material | <1% | 2,233 | $52K |
| 82607 | <1% | 2,690 | $52K | |
| 86803 | <1% | 4,852 | $49K | |
| 86923 | <1% | 1,648 | $49K | |
| 69436 | Tympanostomy (requiring insertion of ventilating tube), general anesthesia | <1% | 26 | $47K |
| 95700 | <1% | 408 | $46K | |
| 99233 | Hospital visit by a doctor, follow-up day (complex) | <1% | 501 | $45K |
| 44970 | <1% | 15 | $44K | |
| 81025 | <1% | 10,047 | $44K | |
| 99291 | Critical care, evaluation and management of the critically ill patient, first 30-74 minutes | <1% | 231 | $43K |
| 71046 | Radiologic examination, chest; 2 views | <1% | 13,242 | $42K |
| 82805 | <1% | 2,171 | $41K | |
| 76801 | <1% | 263 | $38K | |
| 92611 | <1% | 351 | $37K | |
| 87801 | Infectious agent detection by nucleic acid; amplified probe, multiple organisms | <1% | 720 | $35K |
| 82803 | <1% | 1,213 | $35K | |
| 99232 | Hospital visit by a doctor, follow-up day | <1% | 557 | $34K |
| 99204 | Doctor's office visit, new patient (more involved) | <1% | 240 | $34K |
| 83520 | <1% | 1,854 | $32K | |
| A0225 | Ambulance service, neonatal transport, base rate, emergency transport, one way | <1% | 53 | $32K |
| 99223 | Prolong inpt eval add15 m | <1% | 184 | $32K |
| 70491 | <1% | 89 | $31K | |
| 10060 | <1% | 81 | $31K | |
| 76536 | <1% | 894 | $31K | |
| 82570 | <1% | 4,230 | $30K | |
| 87340 | <1% | 2,357 | $29K | |
| 86334 | <1% | 797 | $27K | |
| 76885 | <1% | 822 | $27K | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 12,112 | $27K |
| 85027 | <1% | 8,218 | $26K | |
| 76000 | <1% | 82 | $25K | |
| 83001 | <1% | 731 | $25K | |
| 88112 | <1% | 417 | $25K | |
| 86376 | <1% | 964 | $25K | |
| 86140 | <1% | 8,437 | $23K | |
| 80069 | <1% | 1,299 | $23K | |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | <1% | 25,541 | $23K |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 2,931 | $23K |
| 95819 | <1% | 368 | $23K | |
| 97530 | Therapeutic activities, direct patient contact, each 15 minutes | <1% | 510 | $22K |
| 87070 | <1% | 2,922 | $22K | |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | <1% | 19,177 | $22K |
| 94010 | <1% | 1,195 | $22K | |
| 71250 | <1% | 165 | $21K | |
| 83002 | <1% | 638 | $21K | |
| 83550 | <1% | 2,933 | $21K | |
| 85610 | <1% | 6,870 | $21K | |
| 82043 | <1% | 2,356 | $20K | |
| 76881 | <1% | 311 | $20K | |
| 84146 | <1% | 581 | $20K | |
| 83655 | <1% | 859 | $19K | |
| 85730 | <1% | 5,594 | $19K | |
| 87088 | <1% | 3,129 | $19K | |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 175 | $19K |
| 83690 | <1% | 10,514 | $19K | |
| 86592 | <1% | 4,452 | $19K | |
| J1170 | Injection, hydromorphone, up to 4 mg | <1% | 4,041 | $18K |
| 82533 | <1% | 635 | $18K | |
| 87186 | <1% | 2,485 | $18K | |
| 84165 | <1% | 1,421 | $18K | |
| 88184 | <1% | 528 | $17K | |
| 84702 | <1% | 4,965 | $17K | |
| 86800 | <1% | 712 | $17K | |
| 83735 | <1% | 9,282 | $16K | |
| 86706 | <1% | 1,119 | $16K | |
| 82670 | <1% | 317 | $16K | |
| 81001 | <1% | 13,551 | $16K | |
| 82746 | <1% | 941 | $16K | |
| 77336 | <1% | 25 | $15K | |
| J1650 | Injection, enoxaparin sodium, 10 mg | <1% | 934 | $15K |
| 86920 | <1% | 399 | $15K | |
| 83921 | <1% | 414 | $15K | |
| 86618 | <1% | 1,430 | $15K | |
| 86704 | <1% | 950 | $14K | |
| 87081 | <1% | 3,356 | $14K | |
| 80076 | <1% | 910 | $14K | |
| 86762 | <1% | 914 | $13K | |
| 84153 | <1% | 412 | $12K | |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 2,202 | $12K |
| 86003 | <1% | 225 | $12K | |
| 99404 | <1% | 88 | $12K | |
| A9575 | Injection, gadoterate meglumine, 0.1 ml | <1% | 1,740 | $11K |
| 82565 | <1% | 8,406 | $11K | |
| 84484 | <1% | 9,241 | $11K | |
| 82310 | <1% | 7,351 | $11K | |
| 84100 | <1% | 7,443 | $11K | |
| 87481 | <1% | 237 | $10K | |
| 77072 | <1% | 646 | $10K | |
| 85652 | <1% | 7,201 | $10K | |
| 93325 | <1% | 207 | $10K | |
| 78815 | Positron emission tomography (PET) for limited area imaging | <1% | 12 | $10K |
| 93010 | Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | <1% | 1,283 | $9K |
| 81513 | <1% | 197 | $9K | |
| 84480 | <1% | 969 | $9K | |
| 80197 | <1% | 710 | $9K | |
| 86039 | <1% | 1,056 | $9K | |
| C1889 | Implantable/insertable device, not otherwise classified | <1% | 13 | $9K |
| J1815 | Injection, insulin, per 5 units | <1% | 1,521 | $9K |
| M0243 | Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring | <1% | 19 | $8K |
| 84156 | <1% | 1,994 | $8K | |
| J8499 | Prescription drug, oral, non chemotherapeutic, nos | <1% | 1,823 | $8K |
| 36416 | <1% | 1,816 | $8K | |
| 86902 | <1% | 237 | $8K | |
| 97166 | <1% | 49 | $8K | |
| 82962 | <1% | 9,451 | $7K | |
| 74018 | <1% | 1,591 | $7K | |
| J3010 | Injection, fentanyl citrate, 0.1 mg | <1% | 11,616 | $7K |
| 86147 | <1% | 179 | $7K | |
| 95714 | <1% | 17 | $7K | |
| 90791 | Psychiatric diagnostic evaluation | <1% | 38 | $7K |
| 86160 | <1% | 248 | $7K | |
| G0379 | Direct admission of patient for hospital observation care | <1% | 31 | $7K |
| 97165 | <1% | 69 | $7K | |
| 83021 | <1% | 208 | $6K | |
| 83516 | <1% | 537 | $6K | |
| C1894 | Introducer/sheath, other than guiding, other than intracardiac electrophysiological, non-laser | <1% | 562 | $6K |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 2,000 | $6K |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 8,227 | $6K |
| 84520 | <1% | 8,213 | $6K | |
| 86769 | <1% | 144 | $6K | |
| 99203 | Doctor's office visit, new patient (routine) | <1% | 67 | $6K |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 15,163 | $6K |
| 87483 | <1% | 27 | $6K | |
| 75561 | <1% | 12 | $6K | |
| J0780 | Injection, prochlorperazine, up to 10 mg | <1% | 821 | $6K |
| 76604 | <1% | 118 | $6K | |
| 71045 | Radiologic examination, chest; single view | <1% | 4,130 | $6K |
| 0240U | <1% | 2,394 | $6K | |
| J2543 | Injection, piperacillin sodium/tazobactam sodium, 1 gram/0.125 grams (1.125 grams) | <1% | 325 | $5K |
| 97163 | <1% | 24 | $5K | |
| 84311 | <1% | 516 | $5K | |
| A9541 | Technetium tc-99m sulfur colloid, diagnostic, per study dose, up to 20 millicuries | <1% | 29 | $5K |
| 87205 | <1% | 3,412 | $5K | |
| 76937 | <1% | 26 | $5K | |
| 72141 | <1% | 13 | $5K | |
| 87468 | <1% | 122 | $5K | |
| 90460 | Immunization administration through 18 years of age via any route, first or only component | <1% | 186 | $5K |
| 94729 | <1% | 312 | $5K | |
| 82550 | <1% | 4,126 | $5K | |
| U0002 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc | <1% | 106 | $5K |
| 81003 | <1% | 5,811 | $5K | |
| 94060 | <1% | 126 | $5K | |
| 99205 | Prolong outpt/office vis | <1% | 24 | $4K |
| 72148 | Magnetic resonance imaging, lumbar spine; without contrast material | <1% | 14 | $4K |
| 84305 | <1% | 138 | $4K | |
| 85007 | <1% | 2,274 | $4K | |
| 87184 | <1% | 410 | $4K | |
| 83615 | <1% | 1,339 | $4K | |
| 85612 | <1% | 769 | $4K | |
| 88173 | <1% | 96 | $4K | |
| 70360 | <1% | 533 | $4K | |
| 87522 | Neg quan hep c or qual rna | <1% | 56 | $4K |
| 88312 | <1% | 118 | $4K | |
| 95708 | <1% | 95 | $4K | |
| 82627 | <1% | 97 | $4K | |
| 82947 | <1% | 8,147 | $4K | |
| 82040 | <1% | 6,930 | $4K | |
| 73130 | <1% | 1,990 | $4K | |
| 84155 | <1% | 7,083 | $4K | |
| 84295 | <1% | 8,544 | $4K | |
| 82150 | <1% | 1,244 | $4K | |
| 82374 | <1% | 7,833 | $4K | |
| 93351 | <1% | 12 | $4K | |
| 86708 | <1% | 210 | $4K | |
| 93017 | <1% | 26 | $4K | |
| 84075 | <1% | 6,843 | $3K | |
| 82435 | <1% | 7,326 | $3K | |
| 82950 | <1% | 400 | $3K | |
| 87510 | <1% | 1,266 | $3K | |
| 86880 | <1% | 179 | $3K | |
| 87480 | <1% | 1,191 | $3K | |
| 87484 | <1% | 121 | $3K | |
| J3370 | Injection, vancomycin hcl, 500 mg | <1% | 720 | $3K |
| 87469 | <1% | 89 | $3K | |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | <1% | 109 | $3K |
| 86787 | <1% | 211 | $3K | |
| 77001 | <1% | 13 | $3K | |
| 82785 | <1% | 144 | $3K | |
| 90837 | Psychotherapy session, about an hour | <1% | 22 | $3K |
| 85046 | <1% | 1,736 | $3K | |
| 73562 | <1% | 1,464 | $3K | |
| 83020 | <1% | 136 | $3K | |
| 76377 | <1% | 299 | $3K | |
| C1781 | Mesh (implantable) | <1% | 12 | $3K |
| 96376 | <1% | 6,131 | $3K | |
| 87660 | <1% | 1,253 | $3K | |
| A9585 | Injection, gadobutrol, 0.1 ml | <1% | 985 | $2K |
| 86146 | <1% | 66 | $2K | |
| 85246 | <1% | 129 | $2K | |
| 86431 | <1% | 304 | $2K | |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | <1% | 25 | $2K |
| 87040 | <1% | 2,066 | $2K | |
| 72170 | <1% | 1,050 | $2K | |
| 86922 | <1% | 108 | $2K | |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | <1% | 11,045 | $2K |
| 80051 | <1% | 127 | $2K | |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | <1% | 25 | $2K |
| 87507 | <1% | 12 | $2K | |
| J0690 | Injection, cefazolin sodium, 500 mg | <1% | 6,031 | $2K |
| 72100 | <1% | 529 | $2K | |
| 87503 | <1% | 110 | $2K | |
| J2765 | Injection, metoclopramide hcl, up to 10 mg | <1% | 1,504 | $2K |
| M0240 | Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring, subsequent repeat doses | <1% | 32 | $2K |
| 84681 | <1% | 63 | $2K | |
| 86225 | <1% | 240 | $2K | |
| 73630 | <1% | 1,363 | $2K | |
| 88313 | <1% | 203 | $2K | |
| 76506 | <1% | 60 | $2K | |
| 92610 | <1% | 14 | $2K | |
| 82330 | <1% | 1,172 | $2K | |
| 97116 | <1% | 26 | $2K | |
| 83605 | <1% | 7,149 | $2K | |
| 73030 | <1% | 1,207 | $2K | |
| 82248 | <1% | 290 | $2K | |
| 90838 | <1% | 14 | $2K | |
| 82977 | <1% | 213 | $2K | |
| 74019 | <1% | 276 | $1K | |
| 87075 | <1% | 313 | $1K | |
| Q9957 | Injection, perflutren lipid microspheres, per ml | <1% | 117 | $1K |
| 73090 | <1% | 1,465 | $1K | |
| 73110 | <1% | 1,096 | $1K | |
| 92557 | <1% | 50 | $1K | |
| 82375 | <1% | 2,108 | $1K | |
| 86870 | <1% | 30 | $1K | |
| 84436 | <1% | 2,637 | $1K | |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 15,235 | $1K |
| 85240 | <1% | 78 | $1K | |
| 73552 | <1% | 561 | $1K | |
| 85397 | <1% | 64 | $1K | |
| 78264 | <1% | 12 | $1K | |
| 73610 | <1% | 1,462 | $1K | |
| 73590 | <1% | 1,363 | $1K | |
| 76817 | Ultrasound, pregnant uterus, real time with image documentation, transvaginal | <1% | 16 | $1K |
| 85379 | <1% | 1,256 | $1K | |
| 94664 | <1% | 306 | $1K | |
| J1644 | Injection, heparin sodium, per 1000 units | <1% | 1,108 | $1K |
| 87625 | <1% | 163 | $1K | |
| 92567 | <1% | 116 | $1K | |
| J2060 | Injection, lorazepam, 2 mg | <1% | 1,483 | $1K |
| J2704 | Injection, propofol, 10 mg | <1% | 10,282 | $1K |
| 97010 | <1% | 51 | $1K | |
| 99401 | <1% | 24 | $1K | |
| 87102 | <1% | 178 | $1K | |
| J3475 | Injection, magnesium sulfate, per 500 mg | <1% | 205 | $1K |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | <1% | 4,735 | $1K |
| J0171 | Injection, adrenalin, epinephrine, 0.1 mg | <1% | 901 | $991.26 |
| 85245 | <1% | 50 | $969.42 | |
| 89051 | <1% | 497 | $967.15 | |
| J0131 | Injection, acetaminophen, not otherwise specified,10 mg | <1% | 1,157 | $951.77 |
| 82105 | <1% | 87 | $948.75 | |
| J3535 | Drug administered through a metered dose inhaler | <1% | 439 | $914.44 |
| 72040 | <1% | 194 | $913.25 | |
| 86235 | <1% | 31 | $884.12 | |
| 84703 | <1% | 2,741 | $879.10 | |
| 87497 | <1% | 17 | $857.44 | |
| 85384 | <1% | 295 | $854.50 | |
| 96110 | Developmental screening, with scoring and documentation, per standardized instrument | <1% | 93 | $849.36 |
| 95886 | <1% | 39 | $833.39 | |
| Q0162 | Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen | <1% | 4,811 | $785.51 |
| 80164 | <1% | 78 | $768.26 | |
| 76870 | <1% | 100 | $748.56 | |
| 76816 | Ultrasound, pregnant uterus, real time with image documentation, follow-up | <1% | 13 | $673.00 |
| 96367 | <1% | 13 | $660.24 | |
| 87521 | Neg quan hep c or qual rna | <1% | 13 | $656.68 |
| 73080 | <1% | 541 | $649.08 | |
| 74220 | <1% | 38 | $629.28 | |
| 88311 | <1% | 163 | $621.98 | |
| 85014 | <1% | 1,525 | $613.66 | |
| 84550 | <1% | 116 | $599.00 | |
| 87427 | <1% | 39 | $599.00 | |
| 86364 | <1% | 56 | $566.47 | |
| 80320 | <1% | 5,615 | $551.07 | |
| 73070 | <1% | 386 | $548.03 | |
| 85670 | <1% | 61 | $528.95 | |
| 83050 | <1% | 2,087 | $518.72 | |
| 90686 | <1% | 80 | $512.91 | |
| 84630 | <1% | 39 | $500.95 | |
| C1769 | Guide wire | <1% | 2,917 | $496.09 |
| J7030 | Infusion, normal saline solution , 1000 cc | <1% | 1,845 | $483.42 |
| 82164 | <1% | 40 | $481.80 | |
| J7050 | Infusion, normal saline solution, 250 cc | <1% | 4,913 | $480.73 |
| 86705 | <1% | 30 | $477.40 | |
| 80339 | <1% | 994 | $462.06 | |
| 51600 | <1% | 12 | $455.87 | |
| 99153 | Mod sedat endo service >5yrs | <1% | 1,973 | $441.31 |
| J7120 | Ringers lactate infusion, up to 1000 cc | <1% | 431 | $426.30 |
| 82247 | <1% | 595 | $424.45 | |
| 81002 | <1% | 1,295 | $422.12 | |
| 86255 | <1% | 41 | $420.66 | |
| 99152 | <1% | 2,587 | $412.35 | |
| C1725 | Catheter, transluminal angioplasty, non-laser (may include guidance, infusion/perfusion capability) | <1% | 53 | $400.02 |
| 88300 | <1% | 422 | $392.58 | |
| 73502 | <1% | 164 | $364.50 | |
| 82657 | <1% | 848 | $332.55 | |
| 84145 | <1% | 1,192 | $319.27 | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 1,587 | $310.59 |
| 87206 | <1% | 55 | $279.92 | |
| 73120 | <1% | 39 | $276.89 | |
| 86765 | <1% | 12 | $270.48 | |
| 84460 | <1% | 488 | $253.95 | |
| 87015 | <1% | 156 | $243.35 | |
| 94726 | <1% | 13 | $241.21 | |
| 84132 | <1% | 1,447 | $232.33 | |
| 88302 | <1% | 14 | $230.92 | |
| 73560 | <1% | 68 | $226.53 | |
| 87046 | <1% | 39 | $221.25 | |
| 82042 | <1% | 27 | $219.82 | |
| 87045 | <1% | 39 | $203.75 | |
| J1953 | Injection, levetiracetam, 10 mg | <1% | 191 | $189.91 |
| 80203 | <1% | 12 | $177.28 | |
| 95885 | <1% | 13 | $176.30 | |
| V5266 | Battery for use in hearing device | <1% | 12 | $158.40 |
| 73060 | <1% | 416 | $134.12 | |
| 81015 | <1% | 42 | $121.23 | |
| J7999 | Compounded drug, not otherwise classified | <1% | 666 | $119.27 |
| J0137 | Injection, acetaminophen (hikma), not therapeutically equivalent to j0131, 10 mg | <1% | 130 | $113.45 |
| J2272 | Injection, morphine sulfate (fresenius kabi), not therapeutically equivalent to j2270, up to 10 mg | <1% | 1,223 | $97.16 |
| 76010 | <1% | 42 | $84.54 | |
| 85018 | <1% | 51 | $81.81 | |
| 86617 | <1% | 13 | $77.45 | |
| 82010 | <1% | 305 | $58.33 | |
| J8540 | Dexamethasone, oral, 0.25 mg | <1% | 2,276 | $57.00 |
| Q0144 | Azithromycin dihydrate, oral, capsules/powder, 1 gram | <1% | 311 | $54.50 |
| 86308 | <1% | 143 | $52.38 | |
| 73100 | <1% | 132 | $43.44 | |
| 82553 | <1% | 102 | $40.25 | |
| 72080 | <1% | 13 | $30.00 | |
| 82272 | <1% | 28 | $16.92 | |
| 73140 | <1% | 14 | $15.00 | |
| J0330 | Injection, succinylcholine chloride, up to 20 mg | <1% | 58 | $13.58 |
| 92551 | <1% | 12 | $11.24 | |
| J0665 | Injection, bupivicaine, not otherwise specified, 0.5 mg | <1% | 1,169 | $9.00 |
| J2001 | Injection, lidocaine hcl for intravenous infusion, 10 mg | <1% | 475 | $7.67 |
| J2370 | Injection, phenylephrine hcl, up to 1 ml | <1% | 70 | $6.16 |
| J1596 | Injection, glycopyrrolate, 0.1 mg | <1% | 274 | $5.41 |
| J2710 | Injection, neostigmine methylsulfate, up to 0.5 mg | <1% | 528 | $4.53 |
| J2919 | Injection, methylprednisolone sodium succinate, 5 mg | <1% | 252 | $4.10 |
| J2920 | Injection, methylprednisolone sodium succinate, up to 40 mg | <1% | 24 | $2.84 |
| J1642 | Injection, heparin sodium, (heparin lock flush), per 10 units | <1% | 242 | $2.64 |
| J7040 | Infusion, normal saline solution, sterile (500 ml = 1 unit) | <1% | 166 | $1.30 |
| J7620 | Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme | <1% | 785 | $0.95 |
| J7613 | Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg | <1% | 428 | $0.61 |
| Q0163 | Diphenhydramine hydrochloride, 50 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at time of chemotherapy treatment not to exceed a 48 hour dosage regimen | <1% | 588 | $0.08 |
| Q0240 | Injection, casirivimab and imdevimab, 600 mg | <1% | 32 | $0.07 |
| J2003 | Injection, lidocaine hydrochloride, 1 mg | <1% | 99 | $0.06 |
| J1171 | Injection, hydromorphone, 0.1 mg | <1% | 89 | $0.03 |
| G1004 | Clinical decision support mechanism national decision support company, as defined by the medicare appropriate use criteria program | <1% | 1,752 | $0.03 |
| J2930 | Injection, methylprednisolone sodium succinate, up to 125 mg | 0% | 74 | $0.00 |
| J2550 | Injection, promethazine hcl, up to 50 mg | 0% | 82 | $0.00 |
| C1729 | Catheter, drainage | 0% | 160 | $0.00 |
| Q0177 | Hydroxyzine pamoate, 25 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen | 0% | 167 | $0.00 |
| J0295 | Injection, ampicillin sodium/sulbactam sodium, per 1.5 gm | 0% | 74 | $0.00 |
| 4250F | 0% | 64 | $0.00 | |
| J0670 | Injection, mepivacaine hydrochloride, per 10 ml | 0% | 13 | $0.00 |
| 99157 | 0% | 31 | $0.00 | |
| C1887 | Catheter, guiding (may include infusion/perfusion capability) | 0% | 39 | $0.00 |
| C1760 | Closure device, vascular (implantable/insertable) | 0% | 64 | $0.00 |
| 90461 | 0% | 12 | $0.00 | |
| J2359 | Injection, olanzapine, 0.5 mg | 0% | 21 | $0.00 |
| 3078F | 0% | 57 | $0.00 | |
| 1159F | 0% | 89 | $0.00 | |
| 96127 | 0% | 96 | $0.00 | |
| 80329 | 0% | 563 | $0.00 | |
| J1790 | Injection, droperidol, up to 5 mg | 0% | 128 | $0.00 |
| C9399 | Unclassified drugs or biologicals | 0% | 72 | $0.00 |
| J7042 | 5% dextrose/normal saline (500 ml = 1 unit) | 0% | 96 | $0.00 |
| J2795 | Injection, ropivacaine hydrochloride, 1 mg | 0% | 211 | $0.00 |
| J1630 | Injection, haloperidol, up to 5 mg | 0% | 12 | $0.00 |
| J2371 | Injection, phenylephrine hydrochloride, 20 micrograms | 0% | 85 | $0.00 |
| S2900 | Surgical techniques requiring use of robotic surgical system (list separately in addition to code for primary procedure) | 0% | 102 | $0.00 |
| C1726 | Catheter, balloon dilatation, non-vascular | 0% | 56 | $0.00 |
| 2000F | 0% | 72 | $0.00 | |
| 99156 | 0% | 12 | $0.00 | |
| J7512 | Prednisone, immediate release or delayed release, oral, 1 mg | 0% | 72 | $0.00 |
| J1720 | Injection, hydrocortisone sodium succinate, up to 100 mg | 0% | 19 | $0.00 |
| C1727 | Catheter, balloon tissue dissector, non-vascular (insertable) | 0% | 15 | $0.00 |
| 3008F | 0% | 71 | $0.00 | |
| 3079F | 0% | 14 | $0.00 | |
| 1000F | 0% | 22 | $0.00 | |
| 1036F | 0% | 17 | $0.00 | |
| 3074F | 0% | 58 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialALBERT, FRANCES (EXEC VICE PRESIDENT, CHIEF OPERATIN)
| Provider | Location | Paid |
|---|---|---|
| Albany Medical Center Hospital | Albany, NY | $5.40M |
| Albany Med Niskayuna Ambulatory Endoscopy and Surgery Center | Niskayana, NY | $257K |
| Albany Med Health System | Albany, NY | $1K |
| Albany Medical Center Hospital | Albany, NY | $202.32 |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.